Knowledge graph drug discovery

Life sciences knowledge discovery platform

THE SOLUTION FOR OPTIMIZED DATA MANAGEMENT DRIVING ACCELERATED DRUG DEVELOPMENT

DISQOVER the pharma knowledge graph

DISQOVER is a pioneering knowledge discovery platform specifically crafted for pharmaceutical, biotechnology, and healthcare organizations. DISQOVER links siloed data using knowledge graph and semantic technologies, helping organizations accelerate their drug development activities.

Empowering informed decisions: enhanced insights through linked data

Users gain expanded insights from linked internal, licensed, and public data to power more informed decision making for increased success.

Streamlining drug development: accelerated processes through data integration

Streamlined data integration enables efficient search and analysis across diverse sources to support faster processes across the drug development timeline.

Optimizing data management

Optimize processes, cut duplicative work, and boost project efficacy with faster data access, insights, and collaboration.

Risk mitigation: comprehensive data for increased compliance

With complete data available in DISQOVER that’s readily accessible and enriched, an organization avoids critical mistakes and increases regulatory compliance.

Advancing the FAIR data principles with DISQOVER

Thanks to strong data provenance, interoperable architecture, and powerful data search capabilities, DISQOVER helps companies advance in making their data findable, accessible, interoperable, and reusable.

More about our solution

Developed specifically for life sciences companies, DISQOVER pre-ingests over 70 of the top public data sources relevant to the life sciences field and integrates this data with an organization’s internal and licensed data. This data integration allows users to uncover new insights that help drive new research directions and scientific exploration.

DISQOVER has over 10,000 users ranging from scientific researchers, bioinformaticians, data scientists, and business profiles. Customers include AstraZeneca, Amgen, the Princess Máxima Center for Pediatric Oncology, e-therapeutics, among others.